openPR Logo
Press release

Budesonide Inhaler Market is Develop Rapidly 2019: Pfizer Inc., Cipla Limited, Lupin Limited, Cosmo Pharmaceuticals, Takeda Pharmaceutical Company Ltd., Manus Aktteva Biopharma LLP, Abbott Laboratories, Lunan Better Pharmaceutical, Novartis International

07-02-2019 12:29 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Budesonide Inhaler

Budesonide Inhaler

The global demand for budesonide inhaler is expected to witness substantial growth over the forecast period, owing to increasing incidences and prevalence of asthma. According to the Global Asthma Report 2018, asthma causes around 1000 deaths every day and affects as many as 339 million people worldwide.

Free Request Sample of Report: https://www.coherentmarketinsights.com/insight/request-sample/2551

Furthermore, major players in the market are focused on developing new drug combinations for paediatric use. For instance, in January 2017, AstraZeneca announced that the U.S. FDA approved Symbicort (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of asthma in paediatric patients aged 6 to 12 years. Budesonide/formoterol is already approved in the U.S. to treat asthma in patients 12 years and older and for the maintenance treatment of airflow obstruction in Chronic Obstructive Pulmonary Disease (COPD) in adults.

However, product recalls due to failure to meet regulatory guidelines is expected to hinder the market growth. For instance, in 2014, AstraZeneca’s PULMICORT RESPULES (budesonide inhalation suspension) was recalled by the U.S. FDA as budesonide may be above or below the specification range, which can be harmful for the patients.

Key players in the market are focused on developing generics version of budesonide inhaler in affordable prices and in various forms such as dry powder, aerosols, suspensions or spray for asthma patients. Increasing number of regulatory approvals for generic versions of budesonide inhaler is a major factor driving growth of the budesonide inhaler market. For instance, in 2018, Lupin received approval for its budesonide inhalation suspension 0.5/2ml single dose ampules from the U.S.FDA to market generic versions AstraZeneca’s Pulmicort Respules. It is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age.

Moreover, key manufacturers are also focused on developing new combinations of budesonide inhaler with other drugs to enhance their market share. Budesonide can be made in combination with formoterol. In September 2016, Orion Corporation announced that it has entered into a collaboration agreement with Menarini Group for the co-marketing of budesonide-formoterol Easyhaler combination product in Germany, Italy, Spain, and Portugal. Budesonide-formoterol Easyhaler is an inhaled combination product indicated for asthma and chronic obstructive pulmonary disease (COPD). In this formulation, budesonide acts as an anti-inflammatory agent and formoterol acts as a long-acting bronchodilator. The product is available under the brand name Bufomix Easyhaler in most of the European countries.

Get Free PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/2551

Key players operating in the global budesonide inhaler market include, Pfizer Inc., Cipla Limited, Lupin Limited, Cosmo Pharmaceuticals, Takeda Pharmaceutical Company Ltd., Manus Aktteva Biopharma LLP, Abbott Laboratories, Lunan Better Pharmaceutical, Novartis International AG (Sandoz), Mylan N.V., Skyepharma, AstraZeneca Plc., Chiesi Farmaceutici S.p.A, Orion Corporation, Santarus Inc., Synmosa Biopharma Corporation, and Shanghai Sine Pharmaceutical Laboratories Co. Ltd.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Budesonide Inhaler Market is Develop Rapidly 2019: Pfizer Inc., Cipla Limited, Lupin Limited, Cosmo Pharmaceuticals, Takeda Pharmaceutical Company Ltd., Manus Aktteva Biopharma LLP, Abbott Laboratories, Lunan Better Pharmaceutical, Novartis International here

News-ID: 1793911 • Views: 391

More Releases from Coherent Market Insights

Automotive Trailer Wheel Rims Market Analysis 2020: By Keyplayers TSW alloys Whe …
Don't Quarantine Your Research, you keep your social distance and we provide you a social DISCOUNT use QUARANTINEDAYS Code in precise requirement and Get FLAT 1000USD OFF on all CMI reports Automotive trailer wheelrimis the exterior edge of a vehicle that holds the tire. The materials used for manufacturing those rims include steel, aluminum alloy, and magnesium among others. It is characterized by its design, diameter, and width. It provides support
Smart Fabrics Market Analysis 2020: By Keyplayers AIQ Smart Clothing Inc., E. I. …
Don't Quarantine Your Research, you keep your social distance and we provide you a social DISCOUNT use QUARANTINEDAYS Code in precise requirement and Get FLAT 1000USD OFF on all CMI reports Smart fabrics, also known as smart garments, smart textiles, electronic textiles, or smart clothing are a type of fabric in which digital components and electronic devices such as LEDs, batteries, integrated circuits, conductors, and others are embedded to offer an
Signal Generator Market Analysis 2020: By Keyplayers Keysight Technologies Inc., …
Don't Quarantine Your Research, you keep your social distance and we provide you a social DISCOUNT use QUARANTINEDAYS Code in precise requirement and Get FLAT 1000USD OFF on all CMI reports A signal generator is an electronic device, which generates signals that are used for testing, designing, and troubleshooting electronic device. Signal generator produces repeating or non-repeating signals in both, digital or analog formats. Signal generator can provide 'ideal' waveforms or
Online Fashion Retail Market Key Companies Profile with Sales FashionandYou, Fet …
Increasing use of mobile applications is a major factor propelling growth of the online fashion retail market. Mobile apps offer important features such as smart filters, latest trend news, virtual trial room, offers and deals, which help consumers to search products of their choice. Moreover, smartphones are an ideal platform for retailers to directly sell products to consumers. Therefore, increasing sells of smartphones is expected to drive the market

All 5 Releases


More Releases for Budesonide

Budesonide Sprays Market Enhancement in Medical Sector Forecast to 2025
Global Budesonide Sprays Market Insights, Forecast To 2025 report offers a comprehensive valuation of the marketplace. It does so via in-depth comprehensions, grateful market growth by pursuing past developments, and studying the present situation and future forecasts based on progressive and likely areas. Each research report supports as a depository of analysis and data for each and every side of the industry, including but not limited to: Regional markets, types,
Budesonide Market to Witness Steady Expansion During 2017 - 2025
With the change in climate and environment, seasonal asthma has become main cause of respiratory ailments. Budesonide is used to control and prevent symptoms such as wheezing and shortness of breath caused by asthma. Budesonide belongs to a class of drugs named as corticosteroids. It works directly to the lungs to make breathing easier by reducing the irritation and swelling of the airways. Budesonide sold under the brand name pulmicort
United States Budesonide Aerosol Market Share Analysis Report 2017
This report analyzes the United States Budesonide Aerosol Market and covers the present scenario, the probable growth prospects and the future prospects. It also focuses on the probable future market landscape and the overall positive factors. The report gives an overview of the Budesonide Aerosol Market, the scope of the product, its application and the Global Market Size. Request a Sample Copy of this Report @ https://www.reportsmonitor.com/request-sample/?post=469597  The geographical split of this product can
Budesonide Market to Technological Innovations During 2017 - 2025
With the change in climate and environment, seasonal asthma has become main cause of respiratory ailments. Budesonide is used to control and prevent symptoms such as wheezing and shortness of breath caused by asthma. Budesonide belongs to a class of drugs named as corticosteroids. It works directly to the lungs to make breathing easier by reducing the irritation and swelling of the airways. Budesonide sold under the brand name pulmicort
Global Budesonide Market 2017- Cosmo Pharmaceuticals, Mylan, Teva, Sandoz
Global Budesonide Market 2017, presents a professional and in-depth study on the current state of the Budesonide market globally, providing basic overview of Budesonide market including definitions, classifications, applications and industry chain structure. Historical data available in the report elaborates on the development of the Budesonide market on a global and regional level. The report compares this data with the current Budesonide state of the market and thus discuss upon
Budesonide Market Market to Register Unwavering Growth During 2017 – 2025
Global Budesonide Market: Market Overview With the change in climate and environment, seasonal asthma has become main cause of respiratory ailments. Budesonide is used to control and prevent symptoms such as wheezing and shortness of breath caused by asthma. Budesonide belongs to a class of drugs named as corticosteroids. It works directly to the lungs to make breathing easier by reducing the irritation and swelling of the airways. Budesonide sold under